Exelixis (EXEL) Share-based Compensation (2010 - 2026)
Exelixis' Share-based Compensation came in at $32.56 million for Q2 2027, down 9.7% from $36.07 million a year earlier but up 12.1% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 3, 2026, Exelixis reported Share-based Compensation of $112.6 million, up 1.1% year-over-year; for FY2026, it came in at $112.98 million, up 20.4% from FY2025.
- Share-based Compensation carries a five-year compound annual growth rate of -1.2% (FY2021 to FY2026).
- Going back by year, Share-based Compensation was $93.84 million in FY2025, $106.35 million in FY2023 (-1.1%) and $107.57 million in FY2022 (-10.2%).
- The five-year range for quarterly Share-based Compensation is $19.11 million (Q1 2025) to $36.07 million (Q2 2026).
- Year-over-year, Share-based Compensation increased in four of the last six quarters, with growth averaging 15.1%.
- Business Quant data shows EXEL's Share-based Compensation at $29.05 million (Q1 2027), $20.1 million (Q4 2026) and $30.89 million (Q3 2026) in the three quarters before Q2 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Exelixis | 14.53 Bn | 10.86 Bn | 608.03 Mn | 32.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 32.56 Mn |
| Apr 3, 2026 | 29.05 Mn |
| Jan 2, 2026 | 20.10 Mn |
| Oct 3, 2025 | 30.89 Mn |
| Jul 4, 2025 | 36.07 Mn |
| Apr 4, 2025 | 25.93 Mn |
| Jan 3, 2025 | 26.35 Mn |
| Sep 27, 2024 | 23.02 Mn |
| Jun 28, 2024 | 25.35 Mn |
| Mar 29, 2024 | 19.11 Mn |
| Dec 29, 2023 | 24.31 Mn |
| Sep 29, 2023 | 40.48 Mn |
| Jun 30, 2023 | 24.90 Mn |
| Mar 31, 2023 | 16.66 Mn |
| Dec 30, 2022 | 25.86 Mn |
| Sep 30, 2022 | 37.34 Mn |
| Jul 1, 2022 | 24.62 Mn |
| Apr 1, 2022 | 19.76 Mn |
| Dec 31, 2021 | 23.17 Mn |
| Oct 1, 2021 | 33.97 Mn |
API Access
Exelixis Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();